These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16202686)

  • 1. Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Semin Oncol; 2005 Aug; 32(4):403-13. PubMed ID: 16202686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelofibrosis with myeloid metaplasia: therapeutic options in 2003.
    Mesa RA
    Curr Hematol Rep; 2003 May; 2(3):264-70. PubMed ID: 12901349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
    Faoro LN; Tefferi A; Mesa RA
    Eur J Haematol; 2005 Feb; 74(2):117-20. PubMed ID: 15654901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
    Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
    Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal hypertension complicating myelofibrosis: reversal following splenectomy.
    Lukie BE; Card RT
    Can Med Assoc J; 1977 Oct; 117(7):771-2. PubMed ID: 907949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new.
    Tefferi A
    Semin Hematol; 2003 Jan; 40(1 Suppl 1):18-21. PubMed ID: 12682877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
    Akpek G; McAneny D; Weintraub L
    J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment.
    Koch CA; Li CY; Mesa RA; Tefferi A
    Mayo Clin Proc; 2003 Oct; 78(10):1223-33. PubMed ID: 14531481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated and preemptive palliative radiotherapy of symptomatic hepatomegaly in a patient with advanced myelofibrosis.
    Riesterer O; Gmür J; Lütolf U
    Onkologie; 2008 Jun; 31(6):325-7. PubMed ID: 18547974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
    Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
    Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of splenectomy in myelofibrosis with myeloid metaplasia.
    Barugola G; Cavallini A; Lipari G; Armatura G; Mantovani W; Baggio E
    Minerva Chir; 2010 Dec; 65(6):619-25. PubMed ID: 21224796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.
    Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A
    Best Pract Res Clin Haematol; 2006; 19(3):495-517. PubMed ID: 16781486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches in the treatment of myelofibrosis.
    Hennessy BT; Thomas DA; Giles FJ; Kantarjian H; Verstovsek S
    Cancer; 2005 Jan; 103(1):32-43. PubMed ID: 15565565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
    Sankar K; Pettit K
    Curr Hematol Malig Rep; 2020 Oct; 15(5):391-400. PubMed ID: 32827272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy for symptomatic hepatomegaly in myelofibrosis with myeloid metaplasia.
    Tefferi A; Jiménez T; Gray LA; Mesa RA; Chen MG
    Eur J Haematol; 2001 Jan; 66(1):37-42. PubMed ID: 11168506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.